Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mark Purcell's Stock Ratings
Morgan Stanley Analyst
Mark Purcell is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2025
Overall Average Return
-9.99%
Smart Score
Overall Average Return Percentile
20th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/23/2024 | NVS | Buy Now | Novartis | $112.52 | 1.32% | Mark Purcell30% | → $114 | Initiates | → Equal-Weight | Get Alert |
| 01/23/2024 | SNY | Buy Now | Sanofi | $51.29 | 7.23% | Mark Purcell30% | → $55 | Initiates | → Equal-Weight | Get Alert |
| 01/23/2024 | GSK | Buy Now | GSK | $38.66 | 13.81% | Mark Purcell30% | → $44 | Initiates | → Equal-Weight | Get Alert |
| 01/23/2024 | AZN | Buy Now | AstraZeneca | $70.83 | 20.01% | Mark Purcell30% | → $85 | Initiates | → Overweight | Get Alert |
| 01/23/2024 | NVO | Buy Now | Novo Nordisk | $67.30 | 78.31% | Mark Purcell30% | → $120 | Initiates | → Overweight | Get Alert |
